tiprankstipranks
Monopar Therapeutics Inc (MNPR)
NASDAQ:MNPR
US Market
Want to see MNPR full AI Analyst Report?

Monopar Therapeutics Inc (MNPR) Blogger Opinions & Sentiment

582 Followers

Blogger Sentiment

Bullish: 100.00%
Sector Average
Bullish
MNPR Blogger sentiment is based on 4 Blogger Opinions. The Blogger sentiment is more Bullish than other stocks in the Healthcare sector.

Blogger Article Distribution

ArticleDistribution
75% SeekingAlpha
25% Investing
The distribution of articles among the main online Financial Blogging platforms.

Top Blogger Bearish Predictions

Not enough top blogger opinions at this time
Please return soon. This page is being updated.
Recent negative articles by top bloggers.

Top Blogger Bullish Predictions

Monopar: A Rare Disease Asset With Heavy-Metal Upside (Initiating Buy)
SeekingAlpha
Monopar Therapeutics: ALXN1840's Bull Case Has Improved
SeekingAlpha
Cantor Fitzgerald reiterates Monopar stock Overweight rating at $109
Investing
Recent positive articles by top bloggers.

Financial Blogger Predictions​​

Blogger Performance
Any
Any
Blogger Sentiment
Any
Any

FAQ

What do Seeking Alpha bloggers think of MNPR?
Seeking Alpha’s Willow Tree Research has a Bullish Sentiment.
    What do Motley Fool contributors think of MNPR?
    Currently there's no blogger sentiment for MNPR.
    What Is MNPR’s Blogger Sentiment?
    MNPR’s Blogger Sentiment is Bullish.
      What was the most recent blogger prediction for MNPR?
      The most recent blogger prediction for MNPR was made by Willow Tree Research, who was Bullish on the stock.
        How can I follow the stock ratings of top Top Financial Bloggers?
        Head over to our Expert Center to see a list of the Top 100 Financial Bloggers and follow the financial bloggers of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Stocks with the Highest Top Blogger Ratings in the Healthcare sector
          CADLCandel Therapeutics
          MLTXMoonLake Immunotherapeutics
          CLVLFClinuvel Pharmaceuticals
          ZVRAZevra Therapeutics
          SMMTSummit Therapeutics